Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus N, Denmark
Viborg Regional Hospital, Viborg, Midtjylland, Denmark.
BMJ Open. 2022 Jul 7;12(7):e060410. doi: 10.1136/bmjopen-2021-060410.
The Health in Central Denmark (HICD) cohort is a newly established cohort built on extensive questionnaire data linked with laboratory data and Danish national health and administrative registries. The aim is to establish an extensive resource for (1) gaining knowledge on patient-related topics and experiences that are not measured objectively at clinical health examinations and (2) long-term follow-up studies of inequality in diabetes and diabetes-related complications.
A total of 1.3 million inhabitants reside in the Central Denmark Region. Using register data and a prespecified diabetes classification algorithm, we identified 45 507 persons aged 18-75 years with prevalent diabetes on 31 December 2018 and a group without diabetes of equal size matched by sex, age and municipality. A 90-item questionnaire was distributed to eligible members of this cohort on 18 November 2020 (estimated time required for completion: 15-20 min).
We invited 90 854 persons to take part in the survey, of whom 51 854 answered the questionnaire (57.1%). Among these respondents, 2,832 persons had type 1 diabetes (55.9%), 21,140 persons had type 2 diabetes (53.2%), while 27,892 persons were part of the matched group without diabetes (60.4%). In addition to questionnaire data, the cohort is linked to nationwide registries that provide extensive data on hospital diagnoses and procedures, medication use and socioeconomic status decades before enrolment while laboratory registries has provided repeated measures of biochemical markers, for example, lipids, albuminuria and glycated haemoglobin up to 10 years before enrolment.
The HICD will serve as an extensive resource for studies on patient-related information and inequality in type 1 diabetes and type 2 diabetes. Follow-up is planned to continue for at least 10 years and detailed follow-up questionnaires, including new topics, are planned to be distributed during this period, while registry data are planned to be updated every second year.
丹麦中部健康(HICD)队列是一个新建立的队列,基于广泛的问卷调查数据与实验室数据和丹麦国家健康与行政登记册相链接。其目的是建立一个广泛的资源,用于(1)了解在临床健康检查中无法客观测量的与患者相关的主题和体验,以及(2)对糖尿病和糖尿病相关并发症的不平等进行长期随访研究。
丹麦中部地区共有 130 万居民。使用登记数据和预设的糖尿病分类算法,我们确定了 2018 年 12 月 31 日患有糖尿病的 45507 名年龄在 18-75 岁的患者,并根据性别、年龄和市匹配了一个大小相等的无糖尿病组。2020 年 11 月 18 日,向该队列的合格成员分发了一份 90 项的问卷(估计完成时间:15-20 分钟)。
我们邀请了 90854 人参加调查,其中 51854 人回答了问卷(57.1%)。在这些回答者中,有 2832 人患有 1 型糖尿病(55.9%),21140 人患有 2 型糖尿病(53.2%),而 27892 人属于无糖尿病的匹配组(60.4%)。除了问卷调查数据外,该队列还与全国性登记册相链接,这些登记册提供了关于住院诊断和程序、药物使用和社会经济地位的广泛数据,这些数据可以追溯到入组前几十年,而实验室登记册则提供了长达 10 年的生化标志物(如脂质、白蛋白尿和糖化血红蛋白)的重复测量。
HICD 将成为研究 1 型和 2 型糖尿病患者相关信息和不平等的广泛资源。计划继续随访至少 10 年,并计划在此期间分发详细的随访问卷,包括新的主题,而登记册数据计划每两年更新一次。